Public Hearing - April 18, 2017

 

Public Hearing on Alternatives to Incarceration Court Programs and Synthetic Drugs

Washington, DC

Tuesday, April 18, 2017

9:00 a.m. - 2:30 p.m.

Notice

Pursuant to Rule 3.4 of the Rules of Practice and Procedure of the United States Sentencing Commission, a public hearing is scheduled for Tuesday, April 18, 2017, from 9:00 a.m. – 2:30 p.m. (ET).

The public hearing will be held at the Thurgood Marshall Federal Judiciary Building, One Columbus Circle, N.E., Washington, DC in Suite 2-500 (South Lobby). The hearing will be streamed live.

The purpose of the public hearing is for the Commission to receive testimony on alternatives to incarceration programs in the federal court system. The Commission will also receive testimony from experts on synthetic drugs, including their chemical structure, pharmacological effects, trafficking patterns, and community impact.

To receive updates on future events and other Commission activities, visit us on Twitter or subscribe to our e-mail listserve in the website footer below. For questions regarding this notice, e-mail our Public Affairs Office at pubaffairs@ussc.gov or call us at (202) 502‐4500.

Agenda


Panel I.      Alternatives to Incarceration: Design and Study
9:00 a.m. – 9:45 a.m.

Vanessa Price
Director
National Drug Court Institute
National Association of Drug Court Professionals

Shannon Carey, Ph.D.
Co-President and Senior Research Associate
NCP Research

Faye Taxman, Ph.D.
Professor, Criminology, Law and Society Department
Director, Center for Advancing Correctional Excellence
George Mason University

Panel II.      Alternatives to Incarceration: View from the Bench
9:45 a.m. – 11:00 a.m.

Honorable Dolly M. Gee
United States District Court
Central District of California

Honorable Bruce Hendricks
United States District Court
District of South Carolina

Honorable Leo Sorokin
United States District Court
District of Massachusetts

Break
11:00 a.m. – 11:15 a.m.

Panel III.      Drugs: Introduction and Trafficking Patterns
11:15 a.m. – 11:45 a.m.

Eric Wish, Ph.D.
Director
Center for Substance Abuse Research (CESAR)
University of Maryland
College Park, MD

Shontal Linder
Section Chief, Synthetic Drugs and Chemicals Section
Diversion Control Division
Drug Enforcement Administration

Panel IV.      Drugs: Community Impact and Supervised Release
11:45 a.m. – 12:30 p.m.

Captain Osvaldo Tianga
Broward Sheriff’s Office
Broward Country, FL

Dr. John Cunha, DO
Vice-Chief of Emergency Medicine
Holy Cross Hospital, Fort Lauderdale, FL
Medical Director
Emergency Medical Services for the City of Oakland Park, FL

Lisa Rawlings, Ph.D.
Chief of Staff
Court Services and Offender Supervision Agency
Washington, D.C.

Lunch
12:30 p.m. – 1:30 p.m.

Panel V.      Drugs: Chemical Structure and Pharmacological Effects
1:30 p.m. – 2:30 p.m.

Terrence L. Boos, Ph.D.
Section Chief, Drug and Chemical Evaluation Section
Diversion Control Division
Drug Enforcement Administration

Professor Gregory Dudley, Ph.D.
Eberly Family Distinguished Professor and Department Chair
Department of Chemistry
West Virginia University

Rick Doblin, Ph.D.
Founder and Executive Director
Multidisciplinary Association for Psychedelic Studies (MAPS)
MDMA-Assisted Psychotherapy

Adjourn
2:30 p.m.